NCT07332507 2026-03-18Testing the Effect of Teclistamab on Recurrent Plasmablastic LymphomaNational Cancer Institute (NCI)Phase 1 Not yet recruiting30 enrolled
NCT07113496 2025-08-13RN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic MalignanciesThe First Affiliated Hospital with Nanjing Medical UniversityPhase 1 Not yet recruiting27 enrolled